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Resumen 
Un estudio previo indicó que G9P[8] fue el genotipo de rotavirus más prevalente en 22 
comunidades rurales de Esmeraldas y un hospital urbano de Quito, Ecuador durante 
febrero 2005- febrero 2006.  El objetivo del presente estudio fue caracterizar los genotipos 
rotavirales que circularon las mismas áreas rurales durante los años 2006-2007, y el mismo 
hospital urbano durante el año 2007.  En total 990 muestras de heces fueron recolectadas 
en las áreas rurales, de las cuales 84 (74 casos y 14 controles) fueron rotavirus positivas a 
un test inmunocromatográfico.  La genotipificación mediante RT-PCR de todas las 
muestras  positivas demostró que durante 2006 el genotipo más común fue G9 (22%); 
mientras que en 2007 fue G2 (34%).  Las muestras del hospital urbano también 
demostraron un predominio de G2 (53%) vs. G9 (27%).  Tanto en las muestras urbanas 
como rurales G2 se encontró asociado principalmente con P[4].  Una proporción 
considerable de muestras rurales (58%) no pudieron ser genotipificadas, posiblemente 
como consecuencia de una gran variabilidad genética del virus en esta zona.  El rápido 
reemplazo de G9 por G2 y la gran cantidad de aislados rurales no genotipificados refuerza 
la necesidad de establecer sistemas de vigilancia que provean información precisa a 
programas de vacunación contra rotavirus. 
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Abstract 
A previous study indicated that G9P[8] was the most prevalent rotavirus genotype in 22 
rural communities of Esmeraldas and an urban hospital in Quito, Ecuador during February 
2005- February 2006.  The objective of the present study was to characterize the rotavirus 
genotypes that circulated the same rural areas during the years 2006 - 2007 and the same 
urban hospital during the year 2007.  A total of 990 stool samples were collected in the 
rural areas, of which 84 (70 from cases and 14 from controls) were rotavirus positive by an 
immunochromatographic test.  Genotyping of all rotavirus positive samples by RT-PCR 
showed that the most common typeable genotype was G9 (22%) in 2006, but G2 (34%) in 
the following year.  The samples from the urban hospital also showed a predominance of 
G2 (53%) vs. G9 (27%). In the urban as well as the rural samples, G2 was mainly 
associated to P[4].  A large number of rural samples (58%) could not be genotyped, 
possibly as consequence of a high genetic variability of the virus in that area.   The sudden 
replacement of G9 by G2 and the high number of rural untypeable isolates reinforces the 
necessity of establishing surveillance programs to supply accurate information to 
vaccination programs against rotavirus. 
viii 
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1. Introduction 
Rotavirus is the main diarrhea causing agent responsible for 454,000-705,000 children 
deaths each year worldwide (1).  The virus belongs to the Reoviridae family; it has a three 
layered capsid that surrounds a genome made of 11 segments of double stranded RNA.  
The middle capsid layer is composed of the VP6 protein which is the most abundant 
protein of the virus and permits classification into groups A to E based on the presence of 
specific epitopes.  Most human infecting rotaviruses belong to group A (2).  
Proteins VP7 and VP4, also named G and P respectively, conform the outermost layer of 
the capsid.  Both proteins are neutralizing immunogens, and the nucleotide sequences of 
the corresponding genes are utilized for typing purposes The Rotavirus Classification 
Working Group has catalogued 19 VP7 genotypes and 27 VP4 genotypes (3), and a novel 
genotype (G20P[28]) was recently described in Ecuador (4). Globally, G1, G2, G3, G4, 
and G9 are the most predominant genotypes of VP7, whereas P[8], P[4], P[6]and P[9] are 
the most prevalent of VP4 (5, 6). There are uncommon genotypes like G5, G6, G8, and 
G10 that are endemic in certain communities in Brazil, Australia, Malawi, and India 
respectively (5, 6). 
Rotavirus has a large intra and inter genotype diversity because of genetic reassortments, 
point mutations, genomic rearrangement, and genetic recombination (5, 7).  This diversity 
constitutes an important problem for the design of effective vaccines to decrease rotavirus 
associated mortality and morbidity.  Although available rotaviral vaccines have shown to 
protect against severe gastroenteritis caused by genotypes G1, G2, G3, G4 and G9 (8, 9), it 
is still uncertain the degree of cross protection against genotypes not present in vaccines (9, 
10, 11). 
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A previous study on rotavirus genotype prevalence conducted recently in Ecuador showed 
that G9 was the most prevalent rotavirus genotype circulating in 22 rural communities of 
Esmeraldas and a children’s hospital in Quito during February 2005-February 2006 (12).  
The present study constitutes a follow up study of the previous one and therefore covered 
the same areas during the next two subsequent years (2006 and 2007).  Differently from 
most studies of rotavirus genotype prevalence, which are based on hospital samples, the 
results from the rural settings obtained in this study are community based and included 
both asymptomatic and symptomatic patients.  The hospital samples from a distant urban 
location, Quito, were used as an indicator of the representativity of the results obtained in 
rural areas. 
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2. Materials and Methods 
2.1. Study Population and Design 
All protocols have been described elsewhere (12).  Briefly, twenty-two rural communities 
located in the northern coast of Ecuador, were visited two times for 15 days, first between 
May and December, 2006, and the second time between January and July, 2007.  Each 
household was visited in order to capture all cases of diarrhea. For each case of diarrhea, 
three additional stool specimens were randomly collected from controls, one from the 
patient household and two randomly selected from the same community.  Cases were 
defined as individuals with three or more loose stools in a 24h period and controls as 
individuals with no diarrhea within the past 6 days. Rotavirus positive fecal samples from 
the Hospital de Niños Baca Ortiz in Quito were also collected between January 2007 and 
May 2007 for PCR genotyping.  All protocols were approved by the IRB committees of the 
University of Michigan and Universidad San Francisco de Quito. 
2.2. Detection of Rotavirus and RNA extraction 
All fecal samples were tested for rotavirus with the RIDA Quick Rotavirus 
immunochromatographic test (R-Biopharm AG, Darmstadt, Germany), stored in liquid 
nitrogen, and sent to Quito for PCR-genotyping.  RNA from all rotavirus positive samples 
was extracted with the kit QIAamp Viral RNA Mini kit (Qiagen, Germany) and RNA was 
stored at -80°C for further analysis (12). 
2.3. RT-PCR and Multiplex-PCR for rotavirus genotyping 
Rotavirus genotypes were determined with a two step seminested multiplex reverse 
transcription PCR as described elsewhere (12). After viral RNA was denatured at 97°C for 
13 
5 min., retro-transcription and first amplification were carried out using SuperScript III 
RT/Platinum Taq polymerase kit (Invitrogen Corp.).  Primers were added to a final 
concentration of 267nM each, 9Con1 (forward) and 9Con2 (reverse) for the VP7 
amplification (13) or Con3 (forward) and Con2 (reverse) for the VP4 amplification (14).  
Retro-transcription was carried out at 42°C for 45 min and stopped at 96°C for 2 min.  
First amplification cycling parameters were 30 cycles at 94°C for 30s, 50°C for 30s, and 
72°C for 60s.  
Genotypes G and P were determined in a second amplification by using PuReTaq Ready-
To-Go PCR beads (Amersham Biosciences, Piscataway, NJ, USA) and primers at a final 
concentration of 400nM.  For G genotyping, primer 9Con1 and reverse primers 9T-1, 9T-
2, 9T-3P, 9T-4 and 9T-9B (13) were used.  Primer Con3 and reverse primers 1T-1, 2T1, 
3T-1, 4T-1, 5T-1 y ND3 (14) were used for P genotyping.  The cycling parameters were 30 
cycles at 94°C for 30s, 42°C for 30s, and 72°C for 60s and final extension at 72°C for 1 
min.  The amplicons of the second amplification were run on a 2% agarose electrophoresis 
gel and bands were visualized by ethidium bromide staining. 
2.4. Statistical analysis 
Descriptive statistics were used to present all results.  Means were calculated for continuos 
variables and percentages were calculated for categorical variables.  In order to compare 
differences in rotavirus presence among cases and controls, the odds ratio was calculated 
along with its 95% confidence interval which was calculated through Fisher’s chi square 
test.  P values ≤ 0.05 were considered statistically significant. 
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3. Results 
A total of 990 stool samples were collected in two visits to 22 rural communities of the 
northern coast of Ecuador, 281 (28.4%) of these samples were from patients with diarrhea 
and 709 (71.6%) from asymptomatic controls.  The immunochromatographic test showed 
that 84 (8.5%) samples were rotavirus positive, of which 70 (7.1%) were from patients 
with diarrhea while the remaining 14 (1.4%) samples were from asymptomatic controls.  
The presence of diarrhea was significantly associated with rotavirus infection (odds 
ratio=16.5; 95% confidence interval 8.9 to 32.2) (Table 1).  Rotavirus prevalence on a 15 
day period had the highest value (9.8 %) for children under one year of age (Table 1). 
Table 1. Number of rotavirus positive samples by age group 
+ indicates number of rotavirus positive samples with the immunochromatographic test.  OR, odds 
ratio; CI, confidence interval. The CI was calculated  using the Fisher exact test. 
*Not significative (P>0.05). 
**Prevalence on 15 days, obtained from a mean of rotavirus cases per visit.   
A large proportion (58%) of these samples was untypeable for VP4 and VP7 genes (Table 
2).  Another group of rotavirus positive samples could not be completely genotyped, 15 
yielded results only for VP7 and one only for VP4.  Among the typeable samples, G9 was 
the most prevalent genotype during 2006 (22%) followed by genotype G2 (7%). However 
 Age group 
 Missing 
birthdates 
<1 1 - <5 5 - <20 20 - <40 >40 Total 
Cases (+/n) 10/32 19/43 23/128 10/43 2/12 6/23 70/281 
Controls 
(+/n) 
1/48 0/15 2/69 5/294 4/136 2/147 14/709 
OR 
(95%CI) 
--- ∞ 7,3 
(1,7-65,8) 
17,5 
(5,0-68,3) 
6,6* 
(0,5-51,8) 
25,6 
(4,0-268,0) 
16,5 
(8,9-32,2) 
 
Prevalence*
*(%) 
2,7 9,8 2,3 0,4 0,3 0,4 1,0 
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in samples from 2007, G2 was the most prevalent typeable genotype representing 34% of 
all rotavirus positive samples, followed by G9, which accounted for 7%.  In all community 
samples there was no evidence of mixed genotype infection, but two hospital samples 
showed two different G or P types in the same sample. The most frequent G and P 
combinations detected in this study were, G2P[4] and G9P[8].  A separated analysis of 
control and case-patient samples shows that the most prevalente genotypes, that is G2, G9 
and the combinations G2P[4] and G9P[8], were detected in controls as well as case-patient 
(Table 3).  
Table 2. Rotavirus Genotype Combinations detected in stool samples from the rural 
coastal communities and the children hospital in Quito between 2006 and 2007 
 Number of strains detected (%) 
 Coastal communities Quito 
Genotype 2006, first visit 2007, second visit 2007 
G1 PNT 3(5,6) - - 
G2 PNT 1(1,9) 1(3,4) 1(3,3) 
G9 PNT 10(18,5) - 1(3,3) 
GNT P[4] 1(1,9) - - 
G1 P[6] 1(1,9) - - 
G3 P[6] 1(1,9) - - 
G9 P[4] 1(1,9) - - 
G9 P[8] 1(1,9) 2(6,9) 8(26,7) 
G2 P[4] 3(5,6) 9(31,0) 16(53,3) 
G4 P[6] - - 2(6,7) 
G20 P[28] 1(1,9) - - 
G9 P[8]/P[6] - - 1(3,3) 
G4/G9 P[6] - - 1(3,3) 
GNT PNT 31(57,4) 17(58,6) - 
TOTAL 54 29 30 
NT = not typeable 
A subset of 30 samples randomly selected form 102 rotaviral positive samples collected 
from children at the Hospital de Niños Baca Ortiz in 2007, was genotyped by RT-PCR.  
Most of the samples (28 out of 30) were successfully genotyped for both genes; two 
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samples could not be genotyped for the P segment.  The predominant genotype was 
G2P[4] accounting for 53,3% of all samples while G9P[8] occurred in 26,7% of the 
samples.  Two cases of mixed infections were found among the hospital samples (Table 2). 
Table 3. Rotavirus Genotype Combinations detected in stool samples from the rural 
coastal communities between 2006 and 2007 on cases and controls 
 Number of strains detected 
Genotype Cases (%) Controls (%) 
G1 PNT 3(4,3) - 
G2 PNT 1(1,4) 1(7,1) 
G9 PNT 8(11,4) 2(14,3) 
GNT P[4] 1(1,4) - 
G1 P[6] 1(1,4) - 
G3 P[6] 1(1,4) - 
G9 P[4] 1(1,4) - 
G9 P[8] 2(2,9) 1(7,1) 
G2 P[4] 11(15,7) 1(7,1) 
G20 P[28] 1(1,4) - 
GNT PNT 40(57,1) 9(64,3) 
TOTAL 70(100) 14(100) 
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4. Discussion 
The present results show evidence of an abrupt replacement of genotype G9 with G2 in 
two different regions of Ecuador within a two year period.  According to a previous study 
carried out in the same locations during 2005-2006 (12), the most prevalent genotype 
detected in the rural communities and Quito, was G9 with proportions of 72% and 90% 
respectively, while G2 was not found in the 22 rural communities and was a minor 
genotype in samples from the urban hospital.  A more recent study carried out in Ecuador 
by Naranjo et al., reported that during 2006 G9 was the most prevalent genotype found in 
10 different provinces of Ecuador (Azuay, Cotopaxi, Chimborazo, Imbabura, Pichincha, 
Esmeraldas, Guayas, Manabí, Napo and Pastaza) followed by G2 which was found in 
approximately 28% of the samples. (15).  In the present study it was shown that G2 
infection went from 7% in 2006 to 34% in 2007 within the rural settings, and it reached 
57% in the urban hospital during 2007.  Along with this rise on G2 prevalence, a decrease 
of G9 was observed also at both locations.  
 Other studies have also shown that the prevalent rotavirus genotypes circulating within a 
population change in short periods of time (16, 17).  In Chiang Mai, Thailand, during the 
years 2000-2001, the most prevalent genotype was G9; by the year 2003, G2 emerged as 
the prevailing genotype but only to decline again in 2004, when G1 became the most 
common (16).  In Bangladesh a change of the prevailing genotypes, similar to the change 
reported in this study, has also been observed: between years 2001 and 2005 the prevailing 
strains belonged to genotypes G1P[8] and G9P[8], however by the 2005-2006 season 
G2P[4] became predominant (17)  
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Changes in the pattern of prevailing viral genotypes within a population may be explained 
by the interplay between population’s immunity and viral evolution.  The presence of 
antibodies against a serotype of rotavirus  prevent re-infections by the antigenically related 
viruses but may not against other distinct serotypes (2, 5, 10, 18).    The population may 
build up immunity reducing the circulation of G9 and allowing antigenically distinct 
serotypes to infect. Additionally, viral variants possessing greater infective aptitudes may 
emerge only to disappear when populations reach a certain level of herd immunity (19). 
The large proportion of samples from rural communities that could not be genotyped 
constitutes a limitation of this study. Many studies of rotavirus surveillance have reported 
different rates of genotyping failure e.g. 16% in Western Africa (20), ≤2% in Denmark and 
Malawi (21, 22), 0% in Bangladesh and Thailand (16, 17).  In Ecuador, Naranjo et al and 
Endara et al report a similar rate of genotyping failure (18% and 17% respectively) (12, 
15)  
The increased rate of genotyping failure observed within rural communities could be due 
the presence of unusual strains, which often occur in developing countries and they are 
likely to infect humans due to contact with animals (5, 6). These zoonotic infections 
promote the emergence of new genotypes by viral reassortment.  The presence of unusual 
genotypes may explain the greater abundance of what appeared to be untypeable virus in 
samples from rural communities when compared with samples from urban setting.  An 
evidence that supports this theory is that one of the isolates found during this study was a 
rotavirus with novel G and P types (4).  This would suggest that before 2007 the G9 
genotype was able to temporarily supplant indigenous novel strains, explaining the higher 
proportion of isolates that could be typed during 2005 (Figure 1). 
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Figure 1.  Comparation of percent isolates identified in the rural communities of 
Esmeraldas and Quito as genotype G2, G9 by year  
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White: 2005, grey: 2006, black: 2007.  A) Esmeraldas; B) Quito. NT designates undetermined 
types. 'Other' includes genotypes G1, G3, and G4.  The data from 2005 was taken from Endara et 
al, 2007 (12) 
Other causes of genotyping failure may be sample degradation, the presence of false 
positive results in the immunochromatographic test, primer-template mismatch because of 
minor sequence variations (23; 24; 25) or primer competition during nested PCR (26).  
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However these explanations are undermined by two facts: first, stability tests conducted 
with fecal samples (4) and a previous study (27) suggesting that rotaviral particles are very 
stable and; second, genotyping failure was observed almost exclusively in the rural 
samples thus, if the problem was the procedure then a similar percentage of genotyping 
failure would have been found among urban samples as well.  
The impact that vaccination programs may have on this study is none or not significant 
because a vaccine against rotavirus have been administrated freely in Ecuador only after 
July 2007 (28) and by this time all the samples analyzed in this study were already 
collected.  Before July 2007 vaccines were offered in the country but only by pediatricians 
on private consultation and at a relatively expensive price (29). 
To date, no rotaviral vaccine has proved to be adequately effective against G and P protein 
types not present their formulations.  The sudden change of G9 by G2 found in this study, 
and the presence of a considerable high number of untypeable strains in rural areas 
reinforce the need to establish permanent rotaviral surveillance studies to give accurate 
information to vaccination programs. 
21 
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